Northern Trust
CRBP icon

Northern Trust’s Corbus Pharmaceuticals CRBP Stock Holding History

Northern Trust’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$390K Sell
41,504
-190
-0.5% -$1.6K ﹤0.01% 3709
2025
Q4 		$339K Buy
41,694
+14,463
+53% +$179K ﹤0.01% 3789
2025
Q3 		$344K Sell
27,231
-4,420
-14% -$42K ﹤0.01% 3782
2025
Q2 		$218K Sell
31,651
-68,232
-68% -$496K ﹤0.01% 3911
2025
Q1 		$530K Sell
99,883
-3,381
-3% -$29.8K ﹤0.01% 3554
2024
Q4 		$1.22M Buy
103,264
+11,400
+12% +$191K ﹤0.01% 3304
2024
Q3 		$1.9M Buy
91,864
+66,089
+256% +$3.38M ﹤0.01% 3040
2024
Q2 		$1.17M Buy
25,775
+5,764
+29% +$242K ﹤0.01% 3174
2024
Q1 		$785K Buy
+20,011
New +$493K ﹤0.01% 3406
2023
Q1 		– Sell
-6,911
Closed -$22.9K – 4587
2022
Q4 		$22.9K Sell
6,911
-183
-3% -$704 ﹤0.01% 4464
2022
Q3 		$35K Hold
7,094
– – ﹤0.01% 4417
2022
Q2 		$53K Sell
7,094
-13
-0.2% -$126 ﹤0.01% 4386
2022
Q1 		$113K Sell
7,107
-13
-0.2% -$172 ﹤0.01% 4308
2021
Q4 		$132K Sell
7,120
-136
-2% -$3.68K ﹤0.01% 4335
2021
Q3 		$222K Buy
7,256
+145
+2% +$5.72K ﹤0.01% 4124
2021
Q2 		$390K Sell
7,111
-19,471
-73% -$1.08M ﹤0.01% 3822
2021
Q1 		$1.57M Sell
26,582
-1,013
-4% -$66.6K ﹤0.01% 3376
2020
Q4 		$1.03M Sell
27,595
-245
-0.9% -$9.16K ﹤0.01% 3502
2020
Q3 		$1.5M Buy
27,840
+1,833
+7% +$332K ﹤0.01% 3199
2020
Q2 		$6.55M Sell
26,007
-399
-2% -$80.6K ﹤0.01% 2356
2020
Q1 		$4.15M Buy
26,406
+3,214
+14% +$543K ﹤0.01% 2411
2019
Q4 		$3.8M Buy
23,192
+150
+0.7% +$22.2K ﹤0.01% 2754
2019
Q3 		$3.37M Buy
23,042
+2,706
+13% +$471K ﹤0.01% 2786
2019
Q2 		$4.23M Sell
20,336
-667
-3% -$143K ﹤0.01% 2650
2019
Q1 		$4.38M Buy
21,003
+1,437
+7% +$317K ﹤0.01% 2635
2018
Q4 		$3.43M Sell
19,566
-284
-1% -$56.7K ﹤0.01% 2736
2018
Q3 		$4.5M Buy
19,850
+772
+4% +$125K ﹤0.01% 2746
2018
Q2 		$2.89M Buy
19,078
+1,346
+8% +$245K ﹤0.01% 3001
2018
Q1 		$3.25M Buy
17,732
+260
+1% +$58.4K ﹤0.01% 2838
2017
Q4 		$3.72M Buy
17,472
+746
+4% +$160K ﹤0.01% 2784
2017
Q3 		$3.59M Buy
16,726
+648
+4% +$127K ﹤0.01% 2838
2017
Q2 		$3.04M Buy
16,078
+14,320
+815% +$2.81M ﹤0.01% 2912
2017
Q1 		$435K Buy
1,758
+247
+16% +$60.6K ﹤0.01% 3574
2016
Q4 		$383K Sell
1,511
-4
-0.3% -$917 ﹤0.01% 3593
2016
Q3 		$309K Buy
1,515
+441
+41% +$54.9K ﹤0.01% 3621
2016
Q2 		$96K Buy
1,074
+224
+26% +$17.6K ﹤0.01% 3898
2016
Q1 		$46K Hold
850
– – ﹤0.01% 4035
2015
Q4 		$42K Hold
850
– – ﹤0.01% 4075
2015
Q3 		$40K Buy
850
+483
+132% +$32.2K ﹤0.01% 4113
2015
Q2 		$34K Buy
+367
New +$36.9K ﹤0.01% 4108

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust's CRBP Position: Q1 2026 in Review

Northern Trust reduced its Corbus Pharmaceuticals (CRBP) stake by 0.46% in Q1 2026, selling an estimated $1.6K and leaving 41,504 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #3709.

Northern Trust first reported a position in CRBP in Q2 2015 and has held it in 40 quarters since. The position peaked at $6.55M in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Northern Trust held 41,504 shares of Corbus Pharmaceuticals worth $390K as of Q1 2026.
  • Northern Trust sold 190 Corbus Pharmaceuticals shares in Q1 2026, an estimated $1.6K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3709 holding.
  • Northern Trust first reported a position in Corbus Pharmaceuticals in Q2 2015 and has held it in 40 quarters since.
  • Northern Trust's Corbus Pharmaceuticals position peaked at $6.55M in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.